Two-Drug Combo Shows Modest Benefit in Biliary Tract CancerArticle
CURE,
In patients with advanced, heavily pretreated biliary tract solid tumors, Stivarga (regorafenib) plus Bavencio (avelumab) had…
Regomune: A phase II study of regorafenib + avelumab in solid tumors—Results of the biliary tract cancer (BTC) cohort.
Overview of attention for article published in Journal of Clinical Oncology, May 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
Good Attention Score compared to outputs of the same age and source (69th percentile)
Readers on
- mendeley
- 12 Mendeley
